Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists.
Beteiligte Einrichtungen
Abstract
Natalizumab is associated with the potentially life-threatening side-effect progressive multifocal leukoencephalopathy (PML). Little is known about patients' and physicians' risk estimates and attitudes towards natalizumab treatment.
Bibliografische Daten
| Originalsprache | Deutsch |
|---|---|
| Aufsatznummer | 12 |
| ISSN | 1352-4585 |
| Status | Veröffentlicht - 2010 |
| pubmed | 20826527 |
|---|
